SPDL1 and cancer: A potential association between circulating sPD-L1 and inflammatory response, in cancer patients, is suggested by the positive correlation of sPD-L1 levels with ANC, NLR, and CRP, at baseline, and the negative correlation between the soluble protein and AEC, observed during therapy, in NIBIT-MESO-1 patients.